Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-26

Clinical Trial Update: Elagolix for Fertility Enhancement Clinical Trial [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating elagolix for fertility enhancement in women with endometriosis or unexplained infertility has completed, and results have been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Elagolix (elagolix)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Endometriosis, Unexplained Infertility | Phase 2 | Status: COMPLETED | Results posted: 2024-07-26